TB Multimedia Resources

Commonly Requested Multimedia
Illustration of Mycobacterium tuberculosisCdc-image[JPG - 774 KB]

Illustration of Mycobacterium tuberculosis

This graph shows data on TB in the U.S from 1993 to 2018. The total number of reported TB cases is displayed in bars, and the TB rate per 100,000 people is displayed as a line. The graph shows that while decreases in TB cases and TB rates have continued since 1993, the decrease has slowed in recent years. TB case counts in the U.S. ranged from a high point of 25,102 in 1993 to a low of 9,092 in 2018. The U.S. TB rate ranged from a high point of 9.7 in 1993 to a low of 2.8 in 2017 and 2018. The data for 2018 are preliminary. On a right-hand panel there is a close-up of TB data from 2014 to 2018, which shows a plateau in the decline of both cases and rates during this time period. Beneath the data is text that reads: It’s time to eliminate tuberculosis in the U.S.Cdc-image[JPG - 733 KB]

The Path to TB Elimination Is Clear

If you need more information about the data connected to the release, please click the more information button to find accompanying press releases, articles, and reports.

CDC Releases Preliminary 2018 TB Data - March 21, 2019

New preliminary 2018 TB surveillance data present the lowest number of cases on record and also demonstrates the slowed progress toward TB elimination.

This graph shows data on TB in the U.S from 1993 to 2018. The total number of reported TB cases is displayed in bars, and the TB rate per 100,000 people is displayed as a line. The graph shows that while decreases in TB cases and TB rates have continued since 1993, the decrease has slowed in recent years. TB case counts in the U.S. ranged from a high point of 25,102 in 1993 to a low of 9,092 in 2018. The U.S. TB rate ranged from a high point of 9.7 in 1993 to a low of 2.8 in 2017 and 2018. The data for 2018 are preliminary. On a right-hand panel there is a close-up of TB data from 2014 to 2018, which shows a plateau in the decline of both cases and rates during this time period. Beneath the data is text that reads: It’s time to eliminate tuberculosis in the U.S.Cdc-image[JPG - 733 KB]

The Path to TB Elimination Is Clear

This bar graph shows the reported TB rate in the U.S. from 1993 to 2018. Above the chart is text that reads: The path to TB elimination is clear, but progress has slowed in recent years. The U.S. TB rate is displayed as cases per 100,000 people. The graph shows that while decreases in the U.S. TB rate has continued since 1993, the decrease has slowed in recent years. The U.S. TB rate ranged from a high point of 9.7 in 1993 to a low of 2.8 in 2017 and 2018. The data for 2018 are preliminary.  On a right-hand panel there is an image of lungs. Beneath the lungs is text that reads: It’s time to eliminate tuberculosis in the U.S.Cdc-image[JPG - 804 KB]

TB Rates in the U.S., 1993 – 2018 (Preliminary)

This bar graph shows the number of reported TB cases in the U.S. from 1993 to 2018. Above the chart is text that reads: The path to TB elimination is clear, but progress has slowed in recent years. The graph shows that while decreases in U.S. TB cases has continued since 1993, the decrease has slowed in recent years. TB case counts in the U.S. ranged from a high point of 25,102 in 1993 to a low of 9,092 in 2018. The data for 2018 are preliminary.  On a right-hand panel there is an image of lungs. Beneath the lungs is text that reads: It’s time to eliminate tuberculosis in the U.S.Cdc-image[JPG - 807 KB]

TB Cases in the U.S., 1993 – 2018 (Preliminary)

CDC Releases Updated Recommendations for Treatment of Latent TB Infection - June 28, 2018

CDC released updated recommendations for use of once-weekly isoniazid-rifapentine for 12 weeks (3HP) for treatment of latent TB infection. The updated recommendations support expanded use of an effective, shorter, treatment regimen to reach even more people with latent TB infection.

12 Dose Regimen (3HP) for Latent TB Infection TreatmentCdc-image[JPG - 391 KB]

12 Dose Regimen (3HP) for Latent TB Infection Treatment

Latent TB Treatment CostsCdc-image[JPG - 241 KB]

Latent TB Treatment Costs

Tuberculosis Continues to Decline in the U.S. but Progress Towards Elimination Is Slowing - March 22, 2018

Preliminary data show that while TB case counts reached a record low in 2017, the rate of decline is too slow to eliminate TB during this century.

Trends in TB Cases, 1992-2017 (Preliminary)Cdc-image[JPG - 907 KB]

Trends in TB Cases, 1992-2017 (Preliminary)

This line graph shows the TB rates in the United States between 1982 and 2017. There was a resurgence of TB in the mid-1980s with several years of increasing case counts until its peak in 1992. In 1993, case counts began decreasing again. While overall rates have declined since the peak, the decline has slowed significantly from 2012-2017. This slow progress threatens the realization of TB elimination in this century.Cdc-image[JPG - 770 KB]

TB Rates in the United States, 1982-2017 (Preliminary)

This line graph shows the TB rates in the United States between 1982 and 2017. There was a resurgence of TB in the mid-1980s with several years of increasing case counts until its peak in 1992. In 1993, case counts began decreasing again. While overall rates have declined since the peak, the decline has slowed significantly from 2012-2017. This slow progress threatens the realization of TB elimination in this century.Cdc-image[JPG - 772 KB]

Reported TB Cases in the United States, 1982-2017 (Preliminary)

Below are audio clips featuring NCHHSTP Director Jonathan Mermin, MD, MPH. To save the audio clip, right click the audio player and select the “Save audio as…” option.

Latest Analysis of TB Trends in the U.S. Indicates Progress Is Slow - March 23, 2017

Preliminary 2016 data of tuberculosis cases in the United States indicates progress is too slow to eliminate TB in this century.

This line graph shows the TB rates in the United States between 1982 and 2017. There was a resurgence of TB in the mid-1980s with several years of increasing case counts until its peak in 1992. In 1993, case counts began decreasing again. While overall rates have declined since the peak, the decline has slowed significantly from 2012-2017. This slow progress threatens the realization of TB elimination in this century.Cdc-image[JPG - 770 KB]

TB Rates in the United States, 1982-2017

This bar chart shows trends in the number of reported TB cases in the US from 1992 to 2017. Starting with the peak of a resurgence of the disease in 1992, the chart shows a decline in the number of TB cases reported every year from 1992 to 2014, with a slight uptick in cases in 2015 (9,547). Preliminary 2017 data and analysis of trends indicate slight declines in TB cases. A magnified view of 2012 to 2017 shows the slow progress of declines.Cdc-image[JPG - 772 KB]

Reported TB Cases in the United States, 1982-2017

The Costly Burden of Drug-Resistant TB in the U.S. - November 2017

Multidrug-resistant (MDR) tuberculosis is a major health threat globally. Nearly half a million MDR TB cases are estimated to occur worldwide annually, including cases that are extensively drug-resistant (XDR).

Outsized Financial Toll of MDR and XDR TBCdc-image[JPG - 839 KB]

Outsized Financial Toll of MDR and XDR TB

A Major Human CostCdc-image[JPG - 335 KB]

A Major Human Cost

Chlamydia and Gonorrhea infections among YouthCdc-image[JPG - 214 KB]

Chlamydia and Gonorrhea infections among Youth

Preventing and Controlling MDR and XDR TB in the U.S.Cdc-image[JPG - 542 KB]

Preventing and Controlling MDR and XDR TB in the U.S.

Multimedia Archive
Still image from Medscape Commentary about New Treatment for MDR-TB with Dr. Sundari Mase External

"New Treatment for MDR-TB" with Dr. Sundari Mase

Page last reviewed: September 26, 2017